학술논문

753P - Phase II study of weekly cabazitaxel for ‘unfit’ metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. Circulating tumour cell (CTC) analysis (SOGUG-CABASEM Trial)
Document Type
Abstract
Source
In Annals of Oncology 1 October 2016 27 Supplement 6:vi255-vi255
Subject
Language
ISSN
0923-7534